(Q77304829)
Statements
Prevention of graft-versus-host disease (GVHD) by elimination of recipient-reactive donor T cells with recombinant toxins that target the interleukin 2 (IL-2) receptor (English)
Harris DT
Sakiestewa D
Lyons C
Kreitman RJ
1 January 1999